# The Long-term Effect of Perinatal Tissue Mesenchyme Stem Cells in the Treatment for Caesarean Section Scars

> **NCT04034615** · PHASE2 · WITHDRAWN · sponsor: **Maternal and Child Health Hospital of Foshan**

## Conditions studied

- Cicatrix

## Interventions

- **BIOLOGICAL:** Mesenchyme Stem Cells low-dose group
- **BIOLOGICAL:** Mesenchyme Stem Cells high-dose group
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04034615
- **Lead sponsor:** Maternal and Child Health Hospital of Foshan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-05-20
- **Primary completion:** 2021-12-01
- **Final completion:** 2022-06-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The pandemic resulted in no enrollments。
- **Last updated:** 2022-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04034615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04034615, "The Long-term Effect of Perinatal Tissue Mesenchyme Stem Cells in the Treatment for Caesarean Section Scars". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04034615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*